| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Blouse Grant E. is a Chief Scientific Officer at GYRE. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $63K at current prices.
Our model assigns Blouse Grant E. a middling insider score of 51/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +19.3%.
Blouse Grant E.'s largest disclosed position is in GYRE as Chief Scientific Officer, worth about $63K. Net of sales, the recent Form 4 record there shows accumulation of 7,663 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | GYRE Gyre Therapeutics, Inc. | Chief Scientific Officer | Buy | 3,250 | $0.47 | $1,527.50 | +52.7% | +13.8% | +14.8% | |
| Feb 9, 2022 | GYRE Gyre Therapeutics, Inc. | Chief Scientific Officer | Buy | 3,250 | $0.46 | $1,495.00 | +111.4% | -33.9% | +192.0% | |
| Aug 9, 2021 | GYRE Gyre Therapeutics, Inc. | Chief Scientific Officer | Buy | 1,163 | $3.62 | $4,210.06 | +66.3% | -26.5% | -57.0% |